<strong>ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new <em>in vitro </em>and <em>in silico </em>assays that predict T cell responses in vaccines</strong>
ImmuneWatch, Quantoom Biosciences (“Quantoom”) and UAntwerp (Lab of Experimental Hematology) are delighted to announce a public-private partnership in a project under the “Pandemic Preparedness” call, launched by the University of Antwerp in 2022. “The goal of this project is to assess if a detailed analysis of the T-cell receptor response can be utilised to inform […]